Search the Newsreel

Fennec Pharmaceuticals Inc (FENC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Fennec Pharmaceuticals Inc (FENC) focusing on its dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent payouts. The article also presents current stock information …

FENC|Fennec Pharmaceuticals Inc|Price:10.280|Chg%:+0.290

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product PEDMARK, which is used to reduce ototoxicity in pediatric cancer patients undergoing cisplatin treatment. The company utilizes a field force to educate medical communities and patients about PEDMARK and provides patient access …

Uravi Defence and Technology Limited Revenue Breakdown – NSE:URAVIDEF

Fennec Pharmaceuticals Inc. Revenue Breakdown – TSX:FRX

Fennec Pharmaceuticals Inc. (TSX:FRX) generated 61.30 million CAD in revenue last year, primarily from its Sodium Thiosulfate Injection segment. This marks a decrease from the previous year's 68.41 million CAD. The United States was the largest contributor to revenue for both years.

Fennec Pharmaceuticals(FENC) Stock Options Chain | Quotes & News

This article provides details on Fennec Pharmaceuticals (FENC) including its stock options chain, quotes, and news. It likely focuses on financial data and updates relevant to investors.

FENC|Fennec Pharmaceuticals Inc|Price:9.990|

Fennec Pharmaceuticals Inc. (FENC) shows strong fundamentals and growth potential, despite recent weak stock market performance. The company's product, PEDMARK, an approved therapy for cisplatin-induced ototoxicity in pediatric cancer patients, drives its high revenue growth. Analysts have issued "Buy" ratings with a target price …

Defence stocks fall as investors book profits ahead of Q1FY27 earnings, Choice sees seasonally soft quarter, Apollo Micro, Cochin Shipyard, Paras Defence, MIDHANI lead losers

Uravi Defence clarifies audit qualification impact on FY26 results

Paras Defence Shares Rally 28% in 3 Sessions: What Is Driving the Defence Stock?

Paras Defence, HAL, MTAR Tech soar as Nifty India Defence index jumps 3%; key drivers explained

Uravi Defence promoters report no new encumbrances in FY26

From Paras Defence to Apollo Micro, GRSE, Data Patterns: Defence stocks fall despite gains in Indian stock markets

PL Stock Earnings Review: Defence Momentum Drives Planet Labs to Q1 Beat

Data Patterns, Paras Defence soar 9%; zoom up to 111% from 2026 lows

Paras Defence to hold investor meet on May 27

UK's QinetiQ reviews US defence business, lifts 2027 forecast; shares jump

Revenue Beat: Paras Defence and Space Technologies Limited Exceeded Revenue Forecasts By 7.0% And Analysts Are Updating Their Estimates

We Ran A Stock Scan For Earnings Growth And Paras Defence and Space Technologies (NSE:PARAS) Passed With Ease

Paras Defence FY26 Net Profit Rises to ₹8,946 Lakhs; Results Published in Newspapers

Paras Defence Q4 profit jumps 74%; stock extends decline, still up 13% in a month: Target prices, outlook

Paras Defence & Space Technologies Q4 Results: Net Profit Rises 74%, Announce Second Dividend

Uravi Defence and Technology Limited Reports Q3FY26 Consolidated Results with Mixed Operational Performance

Is Now The Time To Put Uravi Defence and Technology (NSE:URAVIDEF) On Your Watchlist?

Uravi Defence Subsidiary Acquires 10% Stake in Spafax International Holdings

Swan Defence stock hits lower circuit after board approves 5% promoter stake sale via OFS route; check floor price

Paras Defence Lands ₹80 Cr DRDO Order — Why Defence Stocks Are Back in Focus

Uravi Defence Completes SKL India Divestment Following Shareholder Approval

Ideaforge, Data Patterns, Paras Defence, BEL, BDL among defence stocks rising up to 15%; here's why

UK's BAE Systems forecasts years of growth in ‘new era’ of defence spending, backlog hits record

Uravi Defence and Technology Limited Announces Q3FY26 Financial Results

Swan Defence and Heavy Industries Schedules Board Meeting for February 04, 2026 to Review Q3FY26 Financial Results

Paras Defence stock: Nirmal Bang cuts target price by 16%, still sees 32% upside

Paras Defence launches semiconductor unit, plans 3D packaging facility

Paras Defence Shareholders Approve Director Reappointment with 99.97% Majority

Paras Defence Shares Surge 14% in a Week on Strong Q2 Results and New Defence Orders

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore